These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8174824)

  • 21. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Japan.
    Yugi H; Hino S; Satake M; Tadodoro K
    Vox Sang; 2005 Nov; 89(4):265. PubMed ID: 16262762
    [No Abstract]   [Full Text] [Related]  

  • 22. Update on HIV infection. HIV antibody testing.
    Matuszak DL; Israel E; Horman JT; Joseph JM
    Md Med J; 1987 Jan; 36(1):40-3. PubMed ID: 3645235
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis B virus blood screening: unfinished agendas.
    Comanor L; Holland P
    Vox Sang; 2006 Jul; 91(1):1-12. PubMed ID: 16756595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic screening for blood-borne viruses in transfusion settings.
    Lee HH; Allain JP
    Vox Sang; 1998; 74 Suppl 2():119-23. PubMed ID: 9704433
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening of blood donors for antibody to human immunodeficiency virus type 1.
    Acquaye JK
    West Afr J Med; 1993; 12(2):93-5. PubMed ID: 8398939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AIDS tests could trigger world blood shortage.
    Sattaur O
    New Sci; 1985 May; 106(1456):6. PubMed ID: 11655709
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of the organization of pre and post transfusion screening of viral infection markers in blood recipients in France in 2001].
    Fressy P; Daurat G; Duedari N; Le Blanc G; Taverne D; Ounnoughène N; Pillonel J
    Transfus Clin Biol; 2005 Oct; 12(4):295-300. PubMed ID: 16055363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [AIDS--a nightmare in our time].
    Osterr Krankenpflegez; 1985 Nov; 38(11):271-2. PubMed ID: 3003653
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serological markers in viral hepatitis].
    Lisker Melman M
    Rev Invest Clin; 1990 Jul; 42 Suppl():3-8. PubMed ID: 19256125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor.
    Dreier J; Kröger M; Diekmann J; Götting C; Kleesiek K
    Transfus Med; 2004 Apr; 14(2):97-103. PubMed ID: 15113374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preventive aspects in the use of serologic markers of the human immunodeficiency virus infection].
    González López E; Puche López N
    Med Clin (Barc); 1990 May; 94(19):733-5. PubMed ID: 2388505
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-level hepatitis B viraemia.
    Howell DR; Eglin R
    Transfus Med; 2005 Feb; 15(1):63; author reply 65-6. PubMed ID: 15713132
    [No Abstract]   [Full Text] [Related]  

  • 34. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
    Yoshikawa A; Gotanda Y; Minegishi K; Taira R; Hino S; Tadokoro K; Ohnuma H; Miyakawa K; Tachibana K; Mizoguchi H;
    Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
    Challine D; Chevaliez S; Pawlotsky JM
    Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
    Aggarwal V; Prakash C; Yadav S; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIDS panic disrupts American blood banks.
    Anderson I
    New Sci; 1983 Jun; 98(1364):927. PubMed ID: 11655536
    [No Abstract]   [Full Text] [Related]  

  • 38. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.
    Rahbar AR; Sundqvist VA; Wirgart BZ; Grillner L; Söderberg-Naucler C
    Transfusion; 2004 Jul; 44(7):1059-66. PubMed ID: 15225248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What are the consequences of indeterminate results in confirmatory tests for antibodies against transmissible viruses?
    Vox Sang; 1997; 73(2):97-104. PubMed ID: 9304779
    [No Abstract]   [Full Text] [Related]  

  • 40. A new Pandora's box: HTLV-3 tests.
    Med World News; 1985 Feb; 26(3):11-2. PubMed ID: 11645543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.